Loading insider details...
Latest Form 4 (Jun 11, 2026): Grant/Award of 70,000 ALDX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/Award | 70,000 | n/a |
| Jun 12, 2025 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/Award | 62,728 | n/a |
| Jun 6, 2024 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/Award | 40,282 | n/a |
| Sep 11, 2023 | Aldeyra Therapeutics, Inc. (ALDX) | Exercise/Conversion | 5,437 | $3.0K |
| Jul 5, 2023 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/Award | 21,222 | n/a |
| Jun 9, 2022 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/Award | 53,812 | n/a |
| Jun 10, 2021 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/Award | 13,534 | n/a |
| Jun 11, 2020 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/Award | 26,503 | n/a |